Critically, since TERT promoter mutations occur in a vast majority of molecularly defined (i.e. IDH-mutant and 1p/19q-codeleted) oligodendrogliomas, assessment of 1p/19q status and exclusion of an IDH mutation by sequencing is usually required before designating a molecular glioblastoma. Here, IDH1 is linked to oligodendroglioma.